Search
for
Sort by
Research 331–360 of 1000+
- Quality-of-Life Assessment in Singaporean Children with Alopecia Areata
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Adult patients with alopecia areata report a significantly better medication adherence compared to those with atopic dermatitis: Results from a large cross-sectional cohort study
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Validation of an Egyptian Arabic Version of Skindex-16 and Quality of Life Measurement in Egyptian Patients with Skin Disease
- Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents with Alopecia Areata
- Survey on Alopecia Areata Patients’ Reported Factors that Determine Severity of Alopecia Areata: A Nationwide Multicenter Study
- Korean Consensus Criteria for the Severity Classification of Alopecia Areata
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IgG and IgA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Automating Hair Loss Labels for Universally Scoring Alopecia From Images
- Az alopecia areata kezelésében alkalmazott baricitinib hatásosságának és biztonságosságának retrospektív vizsgálata = Efficacy and safety of baricitinib treatment in alopecia areata:a retrospective analysis
- Extensive alopecia areata: Not necessarily recalcitrant to therapy!
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- Alopecia Areata
- Factors Affecting the Psychosocial Distress of Patients with Alopecia Areata: A Nationwide Study in Korea
- Retrospective Analysis of Systemic Corticosteroids for Alopecia Areata in Pediatric Patients
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- COMPARATIVE EFFICACY OF TOPICAL CLOBETASOL PROPIONATE 0.05% OINTMENT AND TOPICAL TACROLIMUS 0.1% OINTMENT IN THE TREATMENT OF ALOPECIA AREATA
- Prediction of Long-term Scalp Hair Regrowth at 24 Months in Patients with Alopecia Areata Receiving Ritlecitinib Treatment in the ALLEGRO Clinical Trial Program
- Efficacy of Ritlecitinib in Patients with Alopecia Areata by Extent of Hair Loss: Results from the Phase 2b/3 and Phase 3 ALLEGRO Clinical Trials
- Baricitinib Provides Significant Hair Regrowth In Adolescents With Severe Alopecia Areata: 52-Week Efficacy and Safety Results From A Phase 3 Randomized, Controlled Trial
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Alopecia areata
- Therapeutic Efficacy of Liquid Nitrogen Cryotherapy for Treatment of Alopecia Areata
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Evaluation of quality of life scores and family impact scales in pediatric patients with alopecia areata: a cross‐sectional cohort study